[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100581572":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":30,"centralContacts":34,"locations":44,"responsibleParty":63,"collaborators":26,"id":66,"slug":67,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":71,"acronym":72,"eligibilityCriteria":73,"healthyVolunteers":68,"sex":74,"minAge":75,"maxAge":76,"enrollmentInfo":77,"targetDuration":26,"studyType":80,"phases":81,"briefSummary":83,"conditions":84,"keywords":26,"overallStatus":87,"whyStopped":26,"lastUpdateSubmitDate":88,"lastUpdatePostDateStruct":89,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":97},{"fullName":5,"class":6},"University of Alabama at Birmingham","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Virbrotactile stimulation","EXPERIMENTAL","Four hours of vibrotactile stimulation via a closed loop device if an apnea or bradycardia episode is predicted or detected.",[13],"Device: Closed-loop Vibro-Tactile Stimulator",{"label":15,"type":16,"description":17,"interventionNames":18},"Control","SHAM_COMPARATOR","Four hours of no vibrotactile stimulation via the closed loop device if an apnea or bradycardia episode is predicted or detected.",[19],"Device: Control",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DEVICE","Closed-loop Vibro-Tactile Stimulator","Vibro-Tactile stimulation when bradycardia is predicted or predicted.",[9],null,{"type":22,"name":15,"description":28,"armGroupLabels":29,"otherNames":26},"Sham closed-loop vibrotactile stimulator",[15],[31],{"name":32,"affiliation":5,"role":33},"Colm P. Travers Associate Professor of Pediatrics, M.D.","PRINCIPAL_INVESTIGATOR",[35,40],{"name":36,"role":37,"phone":38,"phoneExt":26,"email":39},"Rachel L. Benz, Clinical Research Nurse Manager, MSN","CONTACT","205-934-2184","rlbenz@uabmc.edu",{"name":41,"role":37,"phone":42,"phoneExt":26,"email":43},"Kimberly M. Armstead Clinical Research Coordinator III, B.S.","205-934-0095","karmstead@uabmc.edu",[45],{"facility":5,"status":26,"city":46,"state":47,"zip":48,"country":49,"countryCode":50,"cosmosGeoPoint":51,"geoPoint":56,"contacts":57},"Birmingham","Alabama","35209","United States","US",{"type":52,"coordinates":53},"Point",[54,55],-86.80249,33.52066,{"lat":55,"lon":54},[58,60,61],{"name":59,"role":37,"phone":38,"phoneExt":26,"email":39},"Rachel L Benz Clinical Research Nurse Manager, MSN",{"name":41,"role":37,"phone":42,"phoneExt":26,"email":43},{"name":62,"role":33,"phone":26,"phoneExt":26,"email":26},"Colm P. Travers, M.D.",{"type":33,"investigatorFullName":64,"investigatorTitle":65,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"Colm Travers","Associate Professor of Pediatrics","100581572","application-to-predict-neonatal-apnea-with-bradycardia-100581572",false,"NCT06852053","Application to Predict Neonatal Apnea With Bradycardia","Application to Predict Neonatal Apnea With Bradycardia (APNeA Study)","APNeA","Inclusion Criteria:\n\n* Documented episodes of apnea with bradycardia over the previous 24 hours.\n* Off ventilatory support\u002FNCPAP for \\> 48 hours prior to study entry\n* Gestational age \\\u003C 32 0\u002F7 weeks' gestation at birth\n* Parents\u002Flegal guardians have provided consent for enrollment\n\nExclusion Criteria:\n\n* a major malformation or a neuromuscular condition that affects respiration or causes apnea, or terminal illness or decision to withhold or limit support.","ALL","22 Weeks","32 Weeks",{"count":78,"type":79},25,"ESTIMATED","INTERVENTIONAL",[82],"NA","This purpose of this study is to reduce or stop apneas and bradycardias in pre-term infants, before they occur using gentle stimulation.",[85,86],"Apnea Neonatal","Bradycardia Neonatal","NOT_YET_RECRUITING","2026-01-22",{"date":90,"type":91},"2026-01-23","ACTUAL",{"date":93,"type":79},"2026-07-01",{"date":95,"type":79},"2027-12-31",{"name":5,"class":6},1]